| Financial Year |
March 31 2023 |
| Monetary Funds |
373,516,903.96 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
89,283,511.64 |
| Accounts Receivable |
454,101,782.79 |
| Advances to Suppliers |
56,066,474.80 |
| Other Receivables |
3,509,724.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
168,625,497.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,002,245.27 |
| Total Current Assets |
1,395,660,316.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
43,045,610.90 |
| Investment Properties |
1,488,348.23 |
| Fixed Assetes |
1,265,412,175.88 |
| Under-construction Projects |
359,356,855.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
78,391,567.55 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
3,289,922.62 |
| Other Non-Current Assets |
1,377,862.00 |
| Sub-Total of Non-Current Assets |
1,757,363,342.42 |
| Total Assets |
3,153,023,659.32 |
| Short-Term Loans |
236,224,277.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
137,429,417.31 |
| Accounts Payable |
119,375,433.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
239,528.94 |
| Taxes Payable |
1,729,986.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,959,072.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,750,570.55 |
| Other Current Liabilities |
955,224.84 |
| Sub-Total of Current Liabilities |
517,265,672.44 |
| Long-term Loans |
50,045,833.33 |
| Bonds Payable |
532,648,670.57 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,012,453.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
639,593,264.94 |
| Total Liabilities |
1,156,858,937.38 |
| Paid-In Capital(Or Share Stock) |
288,755,800.00 |
| Capital Surplus |
594,166,328.42 |
| Surplus Reserve |
280,439,727.58 |
| LESS:Treasury Stock |
72,425,529.27 |
| Undistributed Profits |
831,491,160.18 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,996,164,721.94 |
| Owner's Equity（Stockholder's Equity） |
1,996,164,721.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,153,023,659.32 |
